Dla piper advises akoya biosciences in its us$151 million initial public offering

New york, may 3, 2021 /prnewswire/ -- dla piper represented akoya biosciences, inc. (nasdaq: akya) in its recent initial public offering of 7,567,000 shares of its common stock at a price of $20 per share, including the exercise of the underwriters' option to purchase 987,000 shares of common stock, less underwriting discounts and commissions. akoya offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response.
AKYA Ratings Summary
AKYA Quant Ranking